Schond Greenway
2023 - Mind Medicine (MindMed)
In 2023, Schond Greenway earned a total compensation of $1.1M as Chief Financial Officer at Mind Medicine (MindMed), a 47% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $167,200 |
|---|---|
| Salary | $430,000 |
| Stock Awards | $530,250 |
| Other | $11,424 |
| Total | $1,138,874 |
Greenway received $530.3K in stock awards, accounting for 47% of the total pay in 2023.
Greenway also received $167.2K in non-equity incentive plan, $430K in salary and $11.4K in other compensation.
Rankings
In 2023, Schond Greenway's compensation ranked 1,066th out of 2,978 executives tracked by ExecPay. In other words, Greenway earned more than 64.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,066 out of 2,978 | 64th |
Division Manufacturing | 632 out of 1,637 | 61st |
Major group Chemicals And Allied Products | 430 out of 906 | 53rd |
Industry group Drugs | 419 out of 869 | 52nd |
Industry Medicinal Chemicals and Botanical Products | 7 out of 17 | 59th |
Source: SEC filing on April 26, 2024.
Greenway's colleagues
We found two more compensation records of executives who worked with Schond Greenway at Mind Medicine (MindMed) in 2023.